65 - 74 y (n = 66) | ≥75 y (n = 46) | P-value | |
Age (y) | 69.1 ± 3.0 | 79.8 ± 4.1 | <0.001 |
Male, No. (%) | 38 (57.5) | 27 (58.6) | 0.999 |
Body weight (kg) | 61.3 ± 10.8 | 58.0 ± 10.2 | 0.196 |
BMI (kg/m2) | 24.3 ± 3.8 | 23.8 ± 3.3 | 0.453 |
Duration of Diabetes (y) | 14.4 ± 7.3 | 16.1 ± 8.8 | 0.274 |
HbAc1 (%) | 8.43 ± 0.8 | 8.49 ± 0.7 | 0.725 |
SBP (mmHg) | 126.5 ± 12.5 | 123.8 ± 9.8 | 0.223 |
DBP (mmHg) | 72.9 ± 9.9 | 69.0 ± 10.3 | 0.051 |
eGFR (ml/min/1.73 m2) | 74.6 ± 22.2 | 67.0 ± 19.3 | 0.068 |
Complication† | |||
Hypertension | 41 (62.1) | 34 (73.0) | 0.224 |
Dyslipidemia | 32 (48.4) | 19 (41.3) | 0.563 |
Chronic Heart failure | 5 (7.5) | 1 (2.1) | 0.398 |
OMI | 5 (7.7) | 8 (17.3) | 0.138 |
AF | 1 (1.5) | 2 (4.3) | 0.567 |
ASO | 1 (1.5) | 2 (4.3) | 0.567 |
Stroke | 1 (1.5) | 0 (0.0) | 0.999 |
Other OHA‡ | |||
Metformin | 47 (71.2) | 22 (47.8) | 0.018 |
SU | 31 (46.9) | 27 (58.7) | 0.252 |
Pioglitazone | 6 (9.0) | 7 (15.2) | 0.376 |
αGI | 2 (3.0) | 2 (4.3) | 0.999 |
Insulin | 15 (22.7) | 13 (28.2) | 0.515 |